Compiled from lecture notes, this is a condense but detailed summary of the mitochondrial diseases covered in BHCS3009 module. All the information (and more) is available in one place in a logical order, easy to search and use for revision.
Non-traditional inheritance
• A number of familial diseases which do not conform to patterns expected of Mendelian inheritance
• Do not fit multifactorial inheritance
• 2 main explanations
o Genomic imprinting
o Mitochondrial inheritance
Mitochondria
• Principle sites of ATP production by processes of oxidative phosphorylation
• Most human cells contain several hundred mitochondria
• Mitochondrial DNA (mtDNA) consists of 16,569bp encoding 13 polypeptides, 22 tRNAs and 2
rRNAs
• 2-10 copies of mtDNA in each mitochondrion
• Most of the several hundred polypeptides in mitochondria encoded by nuclear genome
Mitochondrial DNA
• Replication and transcription controlled by
displacement loop – d-loop
Nuclear vs mitochondrial genome
Nuclear genome Mitochondrialgenome
Size (base pairs) 3200 Mb (3.2 x 109 ) 16.6 kb
No. molecules per cell 46 (23/24 different in F/M) thousandscopies of one molecule
Associated protein histones & non-histones largely free of protein
Number of genes ~21,000 protein-coding 37 (13 protein-codingplus 22 tRNAand
22,000+RNA genes ? 2 rRNAgenes)
Gene density 1 gene / 70-140 kb 1 gene / 0.45 kb
Repetitive DNA ~50% very little
Transcription geneby gene continuous
Introns in most genes none
% coding DNA ~2% ~93%
Codon usage different
Recombination at least once per pair of homologues not seen
per meiosis
Inheritance Mendelian (Y paternal) maternal
Mitochondrial function
• Mitochondrial respiratory chain complexes and the oxidative phosphorylation system (OXPHOS)
• Electron/proton pathways along these complexes
• 5 intramitochondrial enzyme complexes
• Complex 1 has 45 subunits, 38 nuclear encoded, 7 mitochondrial encoded
• Variants in any complex can affect function
Mitochondrial disease
• First identified in 1962
• Patient with structurally abnormal mitochondria and a loss of coupling between oxidation and
phosphorylation
• Mutations in genes that regulate mitochondrial functional, both in nuclear DNA and mtDNA
, • 1980s – relevance of mutated mtDNA to human disease
• Matrilinear inheritance applies to those disorders due to variants in mtDNA
• Pedigree of mitochondrial diseases
o Affected males cannot pass disease to his offspring
o Transmission of disease is only through female
o All her offspring, male and female, are affected
o Incomplete penetrance – skips generation where phenotype does not manifest but still
possess variant as next generation shows disease (carriers); affects pedigree analysis
• Largest class of inborn errors of metabolism with collective incidence of 3 in 10,000
• Progressive, debilitating diseases
• May manifest in utero, at birth, childhood or delayed adult onset
• Multisystem disease with very variable clinical progression – any unexplained, progressive,
multisystem illness should be evaluated for mitochondrial disease
• Care includes energy management, physical therapy, nutritional and emotional support
Mitochondrial disease genes
• Subsets of mitochondrial disease genes (338) according to functional roles
• Roles include
o mtDNA maintenance
o expression, translation
o mitochondrial dynamics
o substrate metabolism
o cofactor metabolism
• Modes of inheritance
o Autosomal dominance (AD)
o Autosomal recessive (AR)
o X-linked dominant (XD)
o X-linked recessive (XR)
Nuclear DNA and mitochondrial disease
• Mitochondrial proteins mainly encoded by nuclear genes
• Mutations here can have serious effects on respiratory chain function within mitochondria
• E.g., AR variants in genes encoding proteins in CytC system – SURF1
• E.g., G4.5 (TAZ) is XR – in males, results in Barth syndrome
• E.g., mitochondria myopathy, AD, caused by variants in POLG genes
• Heterogeneity must be present (not all mitochondria affected) else person will die (not viable for
life)
Leigh syndrome
• Clinical diagnosis based mainly on brain imaging, but considerable genetic heterogeneity
• Mutations in nuclear and mtDNA
o Genes in complexes I, II, III, IV or V deficiency
o Genes encoding mt tRNA proteins
o Components of pyruvate dehydrogenase complex
o Some forms of combined OXPHOS deficiency
• More than 90 genes implicated in disorder
Phenotypic heterogeneity
• Wide phenotypic spectrum within and between mt diseases
• Phenotypic variation determined by proportion of mitochondria containing mutation/variant
(depends on level of genetic heterogeneity)
Alle Vorteile der Zusammenfassungen von Stuvia auf einen Blick:
Garantiert gute Qualität durch Reviews
Stuvia Verkäufer haben mehr als 700.000 Zusammenfassungen beurteilt. Deshalb weißt du dass du das beste Dokument kaufst.
Schnell und einfach kaufen
Man bezahlt schnell und einfach mit iDeal, Kreditkarte oder Stuvia-Kredit für die Zusammenfassungen. Man braucht keine Mitgliedschaft.
Konzentration auf den Kern der Sache
Deine Mitstudenten schreiben die Zusammenfassungen. Deshalb enthalten die Zusammenfassungen immer aktuelle, zuverlässige und up-to-date Informationen. Damit kommst du schnell zum Kern der Sache.
Häufig gestellte Fragen
Was bekomme ich, wenn ich dieses Dokument kaufe?
Du erhältst eine PDF-Datei, die sofort nach dem Kauf verfügbar ist. Das gekaufte Dokument ist jederzeit, überall und unbegrenzt über dein Profil zugänglich.
Zufriedenheitsgarantie: Wie funktioniert das?
Unsere Zufriedenheitsgarantie sorgt dafür, dass du immer eine Lernunterlage findest, die zu dir passt. Du füllst ein Formular aus und unser Kundendienstteam kümmert sich um den Rest.
Wem kaufe ich diese Zusammenfassung ab?
Stuvia ist ein Marktplatz, du kaufst dieses Dokument also nicht von uns, sondern vom Verkäufer AH1984. Stuvia erleichtert die Zahlung an den Verkäufer.
Werde ich an ein Abonnement gebunden sein?
Nein, du kaufst diese Zusammenfassung nur für 12,12 €. Du bist nach deinem Kauf an nichts gebunden.
